维普中文期刊产品整合服务
37篇 您的检索式:作者名="Dolff"
    题名 作者 年代 出处 被引量
1Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus显示文摘Dolff S Abdulahad WH Westra J 2011Arthritis Res Ther2011,13,5:1
2Urinary T cells in active lupus nephritis show an effector memory phenotype显示文摘Dolff S Abdulahad WH van Dijk MC 0,,11:1
3Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis显示文摘Dolff S Abdulahad WH Arends S 0,,01:1
4Disturbed Th1,Th2,Th17and T(reg)balance in patients with systemic lupuserythematosus显示文摘Dolff S Bijl M Huitema MG 2011Clin Immunol2011,141,2:1
5Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus显示文摘Dolff S Quandt D Wilde B 0,,04:1
6Disturbed Tbl,Th2,Thl7 and T (reg) balance in patientswith systemic lupus erythematosus显示文摘Dolff S Bijl M Huitema MG 2011Clin lmmunol2011,141,2:1
7CD134 expression on CD4^ + T cells is associated with nephritis and disease aetivity in patients with systemic lupus erythematosus 显示文摘Patschan S Dolff S Kribben A 2006Clin Exp Immunol2006,145,2:1
8CD134 expression on CD4+ T ceils is associated with nephritis and disease activity in patients with systemic lupus erythematosus显示文摘Patschan S Dolff S Kribben A 2006Clin Exp Immunol2006,145,2:1
9Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion? 显示文摘Dolff S Abdulahad W Bijl M 2009Lupus2009,18,7:1
10Urinary od8+ t-cellcounts discriminate between active and inactive lupus nephritis 显示文摘Dolff S Abdulahad WH Arends S 2013Arthritis Res Ther2013,15,1:1
11Repaglinide in the management of new-onset diabetes mellitus after renal transplantation显示文摘Türk T Pietruck F Dolff S 2006Am J Transplant2006,6,:1
12Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus 显示文摘Dolff S Quandt D Wilde B 2010Arthritis Res Ther2010,12,4:1
13A Multipathogen Bile Sample-based PCR Assay Can Guide Empirical Antimicrobial Strategies in Cholestatic Liver Diseases显示文摘Background and objectives:Polymerase chain reaction(PCR)techniques provide rapid detection of pathogens.This pilot study evaluated the diagnostic utility and clinical impact of multiplex real-time PCR(mRT-PCR,SeptiFast)vs.conventional microbial culture(CMC)in bile samples of patients with chronic cholestatic liver diseases(cCLDs),endoscopic retrograde cholangio-pancreatography(ERCP),and peri-interventional-antimicrobial-prophylaxis(pAP).Methods:We prospectively collected bile samples from 26 patients for microbiological analysis by CMC and mRT-PCR.Concordance of the results of both methods was determined by Krippendorff's alpha(α)for inter-rater reliability and the Jaccard index of similarity.Results:mRT-PCR_(bile)and CMC_(bile)results were concordant for only Candida albicans(α=0.8406;Jaccard index=0.8181).mRT-PCR_(bile)detected pathogens in 8/8 cases(100%),CMC_(bile)in 7/8(87.5%),and CMCblood in 5/8(62.5%)with clinical signs of infection.mRTPCR_(bile),CMC_(bile),and CMCblood had identical detection results in 3/8(37.5%)with clinical signs of infection(two Klebsiella spp.and one Enterococcus faecium).The total pathogen count was significantly higher with mRT-PCR_(bile)than with CMC_(bile)(62 vs.31;χ^(2)=30.031,p<0.001).However,pathogens detected by mRT-PCR_(bile)were more often susceptible to pAP according to the patient infection/colonization history(PI/CH)and surveillance data for antibiotic resistance in our clinic(DARC).Pathogens identified by mRT-PC_(Rbile)and resistant to pAP by PI/CH and DARC were likely to be clinically relevant.Conclusions:mRT-PCR in conjunction with CMCs for bile analysis increased diagnostic sensitivity and may benefit infection management in patients with cholestatic diseases.Implementation of mRT-PCR in a bile sample-based diagnostic routine can support more rapid and targeted use of antimicrobial agents in cCLD-patients undergoing ERCP and reduce the rate/length of unnecessary administration of broad-spectrum antibiotics.Michael Jahn Mustafa KÖzçürümez Sebastian Dolff Hana Rohn Dominik Heider Alexander Dechêne Ali Canbay Peter M.Rath Antonios Katsounas 2022Journal of Clinical and Translational Hepatology2022,10,5:1
14Increased expres-sion of costimulatory markers CD134 and CD80 oninterleukin-17 producing T cells in patients withsystemic lupus erythematosus 显示文摘Dolff S?Quandt D Wilde B 2010Arthritis Res T-her2010,12,4:1
15Urinary T cells in active lupus nephritis show an effector memory phenotype 显示文摘Dolff S Abdulahad W H van Dijk M C 2010Ann Rheum Dis2010,69,11:1
16Treatment of lupus nephritis显示文摘Dolff S Berden JH Bijl M 0,,6:1
17Urinary CD8+ T -cell counts discriminate between active and inactive lupus nephritis 显示文摘Dolff S Abdulahad WH Arends S 2013Arthritis res ther2013,15,1:1
18Disturbed Thl , Th2, Th 17 and T(reg)balance in patients with systemic lupus erythematosus 显示文摘Dolff S Bijl M Huitema MG 2011Clin immunol2011,141,2:1
19Incresed expression ofcostimulatory marker CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus显示文摘Dolff S Quandt D 2010Arthritis Res Ther2010,12,:1
20Repaglinide in the management of new-onset diabetes mellitus after renal transplantation显示文摘TURK T PIETRUCK F DOLFF S 2006Am J Transplant2006,6,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费